Sangamo Therapeutics Inc.

NASDAQ: SGMO · Real-Time Price · USD
0.58
0.04 (7.41%)
At close: Aug 15, 2025, 3:59 PM
0.59
1.21%
After-hours: Aug 15, 2025, 07:49 PM EDT

Sangamo Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-19.99M -30.6M -23.4M 10.67M -36.13M -49.09M -60.3M -104.16M -114.51M 21.13M -51.97M -53.16M -43.17M -43.98M -37.5M -47.69M -47.17M -45.94M
Depreciation & Amortization
1.9M 1.92M 2.13M 2.13M 2.57M 2.53M 3.01M 7.42M 6.18M 5.58M 5.44M 5.18M 5M 4.94M 4.86M 4.59M 4.29M 3.9M
Stock-Based Compensation
2.23M 2.6M 3.28M 3.31M 3.06M 2.72M 6.11M 6.19M 6.79M 8.28M 8.25M 7.79M 7.92M 7.69M 8.08M 7.87M 9.48M 7.52M
Other Working Capital
1.6M -4.45M 12.53M 7.61M 666K -2.8M -10.45M -4.24M -7.64M -153.56M -32.04M -14.39M -24.71M -26.87M -19.61M -23.74M -19.89M -27.61M
Other Non-Cash Items
45K -10K -692K 99K 1.07M 4.08M -2K 45.75M -6.53M 57.52M -918K -531K 43K 164K -6M 631K 859K 845K
Deferred Income Tax
-15K 15K -18K 18K n/a n/a -140K 182K n/a n/a n/a n/a n/a n/a n/a n/a 5K 6K
Change in Working Capital
-2.33M -77K 15.34M -4.47M 2.54M -8.89M 783K -2.67M -3.33M -158.81M -17.85M -12.91M -23.78M -27.79M -22.15M -24.83M -20.03M -34.88M
Operating Cash Flow
-18.16M -26.15M -3.35M 11.76M -26.88M -48.66M -50.54M -47.29M -60.71M -66.3M -57.05M -53.62M -53.98M -58.98M -52.71M -59.42M -52.57M -68.55M
Capital Expenditures
-24K n/a -152K -115K n/a n/a -2.67M -2.74M -5.54M -10.2M -7.47M -4.41M -5.45M -2.84M -2.86M -5.21M -7.26M -7.95M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a -40.37M -48.01M -45.93M -50.09M 9.05M n/a n/a 119K n/a -54K -65K
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a -7.44M -15.89M -36.23M -51.77M -95.69M -64.17M -65.76M -37.77M -120.34M -82.11M -97.94M
Sales Maturities Of Investments
n/a n/a n/a n/a n/a 35.84M 40.38M 47.81M 63.9M 82.15M 101.86M 86.64M 98.05M 70.3M 93.27M 186.52M 178.73M 151.24M
Other Investing Acitivies
n/a n/a 1.48M 348K 127K n/a n/a 40.37M 48.01M 45.93M 50.09M -9.05M 33.87M 4.54M -119K 66.18M -54K -65K
Investing Cash Flow
-24K n/a 1.32M 233K 127K 35.84M 37.71M 37.63M 42.47M 35.73M 42.61M -13.46M 28.43M 1.71M 52.63M 60.98M 89.3M 45.29M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.64M 3.37M n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-420K -2.23M -76K -203K 67K -402K 886K -101K 525K -1.11M 514K -1.22M 945K -1.57M 2.11M 616K 3.45M -416K
Financial Cash Flow
28.61M 8.13M 6.99M -203K -533K 22.12M 167K -100K 6.52M 8M 19.54M 43.82M 22.87M -1.57M 2.11M 5.49M 10.02M 15.23M
Net Cash Flow
13.16M -16.74M 2.72M 12.91M -27.55M 8.63M -11.31M -10.32M -11.41M -22.2M 5.87M -23.14M -2.55M -58.62M 1.92M 7.08M 46.9M -8.35M
Free Cash Flow
-18.18M -26.15M -3.5M 11.64M -26.88M -48.66M -53.21M -50.04M -66.25M -76.5M -64.52M -58.03M -59.43M -61.81M -55.57M -64.63M -59.83M -76.5M